P2‐085: VCAM‐1 AS A BIOMARKER OF COGNITIVE DECLINE IN ALZHEIMER'S DISEASE

MLA

Lori A. Daiello, et al. “P2‐085: Vcam‐1 as a Biomarker of Cognitive Decline in Alzheimer’s Disease.” Alzheimer’s & Dementia, vol. 14, July 2018. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........3545ca0572ab684d289e6aeb770e9545&authtype=sso&custid=ns315887.

APA

Lori A. Daiello, Jonathan D. Drake, Brian R. Ott, & Alison B. Chambers. (2018). P2‐085: Vcam‐1 as a Biomarker of Cognitive Decline in Alzheimer’s Disease. Alzheimer’s & Dementia, 14.

Chicago

Lori A. Daiello, Jonathan D. Drake, Brian R. Ott, and Alison B. Chambers. 2018. “P2‐085: Vcam‐1 as a Biomarker of Cognitive Decline in Alzheimer’s Disease.” Alzheimer’s & Dementia 14 (July). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........3545ca0572ab684d289e6aeb770e9545&authtype=sso&custid=ns315887.